Mission Statement
The Teddy Kim Foundation is dedicated to honoring the life of Edward ʺTeddyʺ Kim through support of innovative leukemia research and patient advocacy.
Teddy Kim

Teddy (Edward) Kim was born on September 3, 1984 to mother Sue Kim and father Sung Kim.
He shared a vibrant childhood with his younger brother, William “Billy” Kim. Together they attended schools in Paramus and Wyckoff in New Jersey.
As Teddy grew older, he graduated from Ramapo High School and headed north to attend Boston College. There, Teddy continued to foster lifelong friendships, cultivated a passion for medicine, and developed a dedication to a healthy lifestyle. In 2006, Teddy graduated from Boston College with a degree in Economics, and immediately after, obtained his Masters in Medical Science from Boston University in 2008.
Determined to pursue a career in medicine, he interned at Massachusetts General Hospital, and later joined the New York Eye and Ear Infirmary as a Research Associate. In the summer of 2008, Teddy bridged his two areas of study – finance and medicine – into his role as a Biotechnology Research Associate at Roth Capital Partners, where he worked under the tutelage of Edward Nash and Joseph Pantginis.
On March, 25th 2011 Teddy was diagnosed with Acute Myeloid Leukemia, an affliction characterized by an abnormal growth of white blood cells. Teddy approached his situation with grace, patience, and humility. He never once blamed God, but rather pressed into the Lord knowing that He held a greater plan for Teddy. Although Teddy gave a valiant fight to live, undergoing countless rounds of chemotherapy and eventually a bone marrow transplant, he left us on April 6th, 2012.
To this day, many of the leukemia patients at Weill Cornell Medical Center speak of Teddy’s braveness and jubilant smile. Teddy's loving nature and kind heart allowed him to foster so many strong relationships wherever he went. He always had dreams of helping others in need as he progressed in his career.
He shared a vibrant childhood with his younger brother, William “Billy” Kim. Together they attended schools in Paramus and Wyckoff in New Jersey.
As Teddy grew older, he graduated from Ramapo High School and headed north to attend Boston College. There, Teddy continued to foster lifelong friendships, cultivated a passion for medicine, and developed a dedication to a healthy lifestyle. In 2006, Teddy graduated from Boston College with a degree in Economics, and immediately after, obtained his Masters in Medical Science from Boston University in 2008.
Determined to pursue a career in medicine, he interned at Massachusetts General Hospital, and later joined the New York Eye and Ear Infirmary as a Research Associate. In the summer of 2008, Teddy bridged his two areas of study – finance and medicine – into his role as a Biotechnology Research Associate at Roth Capital Partners, where he worked under the tutelage of Edward Nash and Joseph Pantginis.
On March, 25th 2011 Teddy was diagnosed with Acute Myeloid Leukemia, an affliction characterized by an abnormal growth of white blood cells. Teddy approached his situation with grace, patience, and humility. He never once blamed God, but rather pressed into the Lord knowing that He held a greater plan for Teddy. Although Teddy gave a valiant fight to live, undergoing countless rounds of chemotherapy and eventually a bone marrow transplant, he left us on April 6th, 2012.
To this day, many of the leukemia patients at Weill Cornell Medical Center speak of Teddy’s braveness and jubilant smile. Teddy's loving nature and kind heart allowed him to foster so many strong relationships wherever he went. He always had dreams of helping others in need as he progressed in his career.
About AML
Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow. The word "acute" in acute myelogenous leukemia denotes the disease's rapid progression. It's called myelogenous (my-uh-LOHJ-uh-nus) leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells and platelets. Acute myelogenous leukemia is also known as acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia and acute nonlymphocytic leukemia. (Source: Mayo Clinic)